Editas Medicine, Inc. (NASDAQ:EDIT) Q3 2023 Earnings Conference Call November 3, 2023 8:00 AM ET Company Participants Cristi Barnett - Corporate Communications & IR Gilmore O'Neill - CEO Baisong Mei - CMO Erick Lucera - CFO Linda Burkly - CSO Caren Deardorf - Chief Commercial & Strategy Officer Conference Call Participants Brian Cheng - J.P. Morgan Samantha Semenkow - Citi Joon Lee - Truist Securities Greg Harrison - Bank of America Gena Wang - Barclays Jack Allen - Baird Dae Gon Ha - Stifel Phil Nadeau - T ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _______________________________ FORM 10-Q _______________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ________ Commission File Number 001-37687 _______________________________ ...

https://reportify-1252068037.cos.ap-beijing.myqcloud.com/media/production/s_m_content_2481022083899b1fd07c6210bb763944.html ...

https://reportify-1252068037.cos.ap-beijing.myqcloud.com/media/production/s_m_content_d05160092a660d562f681583280b3081.html ...

https://reportify-1252068037.cos.ap-beijing.myqcloud.com/media/production/s_m_content_ff79b632a4c1c83306ce6e7db9126fb9.html ...

Editas Medicine, Inc. (NASDAQ:EDIT) Q2 2023 Earnings Conference Call August 2, 2023 8:00 AM ET Company Participants Cristi Barnett - Corporate Communications & Investor Relations Gilmore O’Neill - Chief Executive Officer Baisong Mei - Chief Medical Officer Erick Lucera - Chief Financial Officer Conference Call Participants Terence Flynn - Morgan Stanley Samantha Semenkow - Citi Greg Harrison - Bank of America Joon Lee - Truist Securities Gena Wang - Barclays Dae Gon Ha - Stifel Yanan Zhu - Wells Fargo Rick ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ________ Commission File Number 001-37687 EDITAS MEDICINE, INC. (Exact name of registrant as specified in its charter) Delaware 46-4097528 (Sta ...

Editas Medicine, Inc. (NASDAQ:EDIT) EDIT-301 Clinical Update Conference Call June 12, 2023 8:00 AM ET Company Participants Cristi Barnett - Corporate Communications & Investor Relations Gilmore O’Neill - Chief Executive Officer Baisong Mei - Chief Medical Officer Erick Lucera - Chief Financial Officer Conference Call Participants Joon Lee - Truist Securities Phil Nadeau - Cowen & Company Jacques Villefranc - Stifel Lisa Walter - RBC Capital Markets Jay Olson - Oppenheimer Yanan Zhu - Wells Fargo Madhu Kumar ...

Editas Medicine, Inc. (NASDAQ:EDIT) RBC Capital Markets Global Healthcare Conference 2023 May 16, 2023 10:30 AM ET Company Participants Gilmore O'Neill – Chief Executive Officer Baisong Mei – Senior Vice President and Chief Medical Officer Conference Call Participants Luca Issi – RBC Capital Markets Luca Issi All right, great, thanks. Hello, everybody. Luca Issi, Senior Biotech Analyst here at RBC Capital Markets and today is our great privilege to have Editas with us for a fireside chat. Representing the c ...

Editas Medicine, Inc. (NASDAQ:EDIT) Bank of America Global Healthcare Conference Call May 9, 2023 8:00 PM ET Company Participants Gilmore O’Neill - President, CEO & Director Conference Call Participants Gregory Harrison - Bank of America Merrill Lynch Gregory Harrison Final session of the first day of the Bank of America Healthcare Conference. I'm Greg Harrison, one of the biotech analysts here at BofA. And this afternoon, we have Editas Medicine with us represented by Gilmore O'Neill, Chief Executive Offic ...